Tablets Risperidone (6 mg/day) combined with Tablets placebo as control group for 8 weeks

7 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Schizophrenia. Schizophreniaschizophrenia. Schizophreniaschizophrenia. Schizophrenia, unspecifiedschizophrenia. schizophrenia

Phase 2

Sildenafil the treatment of the negative symptoms of schizophrenia

Active, not recruitingIRCT1138901151556N11

Tehran University of Medical SciencesSchizophrenia. Schizophrenia

Start: 2010-03-01Target: 40Updated: 2018-02-22

Granisetron the treatment of schizophrenia

Active, not recruitingIRCT138902241556N14

Tehran University of Medical Sciencesschizophrenia. Schizophrenia

Start: 2010-06-29Target: 30Updated: 2018-02-22

memantine in the treatment of schizophrenia

Active, not recruitingIRCT138902241556N13

Tehran University of Medical Sciencesschizophrenia. Schizophrenia

Start: 2010-06-09Target: 30Updated: 2018-02-22

Modafinil and treatment of schizophrenia

Active, not recruitingIRCT138903131556N16

Tehran University of Medical Sciencesschizophrenia. Schizophrenia

Start: 2010-05-14Target: 40Updated: 2018-02-22

Tropicetron in the treatment of schizophrenia

Active, not recruitingIRCT201106101556N24

Tehran University of Medical Sciencesschizophrenia. Schizophrenia, unspecified

Start: 2011-07-06Target: 50Updated: 2018-02-22

Pioglitazone the treatment of schizophrenia

Active, not recruitingIRCT201110281556N30

Tehran University of Medical Sciencesschizophrenia. schizophrenia

Start: 2011-12-22Target: 30Updated: 2018-02-22

Phase 3

Buspirone in the treatment of schizophrenia

Active, not recruitingIRCT138712051556N8

Tehran University of Medical SciencesSchizophrenia. Schizophrenia

Start: 2006-04-20Target: 46Updated: 2018-02-22

Related Papers

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

2010-12-0119 citations

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.

2010-10-1525 citations